2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups

Arthritis and Rheumatology

Volumn 69, Issue 12, 2017, Pages 2271-2282

  Lundberg, Ingrid E ^a   Tjärnlund, Anna ^a   Bottai, Matteo ^b   Werth, Victoria P ^c   Pilkington, Clarissa ^d   de Visser, Marianne ^e   Alfredsson, Lars ^b   Amato, Anthony A ^f   Barohn, Richard J ^g   Liang, Matthew H ^f   Singh, Jasvinder A ^h,ac   Aggarwal, Rohit ⁱ   Arnardottir, Snjolaug ^b   Chinoy, Hector ^j   Cooper, Robert G ^k   Dankó, Katalin ^l   Dimachkie, Mazen M ^g   Feldman, Brian M ^m   Garcia De La Torre, Ignacio ⁿ   Gordon, Patrick ^o   Hayashi, Taichi ^p   Katz, James D ^q   Kohsaka, Hitoshi ^r   Lachenbruch, Peter A ^s   Lang, Bianca A ^t   Li, Yuhui ^u   Oddis, Chester V ⁱ   Olesinska, Marzena ^v   Reed, Ann M ^w   Rutkowska Sak, Lidia ^x   Sanner, Helga ^y   Selva O'Callaghan, Albert ^z   Song, Yeong Wook ^aa   Vencovsky, Jiri ^ab   Ytterberg, Steven R ^ac   Miller, Frederick W ^ad   Rider, Lisa G ^ad   more..

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^d GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^h BIRMINGHAM VA MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^j MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^k UNIVERSITY OF LIVERPOOL   (United Kingdom)

^l UNIVERSITY OF DEBRECEN   (Hungary)

^m HOSPITAL FOR SICK CHILDREN   (Canada)

ⁿ UNIVERSITY OF GUADALAJARA   (Mexico)

^o KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^p UNIVERSITY OF TSUKUBA   (Japan)

^q NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^r TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^s OREGON STATE UNIVERSITY   (United States)

^t IWK HEALTH CENTRE   (Canada)

^u PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^v NATIONAL INSTITUTE OF GERIATRICS   (Poland)

^w DUKE UNIVERSITY   (United States)

^x INSTITUTE OF RHEUMATOLOGY   (Poland)

^y OSLO UNIVERSITY HOSPITAL   (Norway)

^z HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^aa Seoul National University College of Medicine   (South Korea)

^ab CHARLES UNIVERSITY   (Czech Republic)

^ac Mayo Clinic   (United States)

^ad NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CLASSIFICATION; CLINICAL ASSESSMENT TOOL; COHORT ANALYSIS; CONTROLLED STUDY; DATA COLLECTION METHOD; DERMATOLOGY; DERMATOMYOSITIS; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE CLASSIFICATION; FEMALE; HUMAN; INCLUSION BODY MYOSITIS; JUVENILE DERMATOMYOSITIS; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MITOCHONDRIAL MYOPATHY; MOTOR NEURON DISEASE; MULTICENTER STUDY; MUSCLE BIOPSY; MUSCULAR DYSTROPHY; MYOPATHY; MYOSITIS; NEUROLOGY; NEUROMUSCULAR DISEASE; NEUROPATHY; PEDIATRIC HOSPITAL; PRIORITY JOURNAL; PROBABILITY; RECEIVER OPERATING CHARACTERISTIC; RHEUMATOLOGY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SKIN BIOPSY; BIOPSY; CONSENSUS; EUROPE; MEDICAL SOCIETY; PATHOLOGY; PRACTICE GUIDELINE; PROCEDURES; SKELETAL MUSCLE; STANDARDS; SYMPTOM ASSESSMENT; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; BIOPSY; CHILD; CONSENSUS; EUROPE; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MYOSITIS; PRACTICE GUIDELINES AS TOPIC; RHEUMATOLOGY; SENSITIVITY AND SPECIFICITY; SOCIETIES, MEDICAL; SYMPTOM ASSESSMENT; UNITED STATES; YOUNG ADULT;

EID: 85035084341     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.40320     Document Type: Article

References (37)

1. Plotz PH, Rider GL, Targoff IN, Raben N, O'Hanlon TP, Miller FW. Myositis: immunologic contributions to understanding cause, pathogenesis, and therapy. Ann Intern Med 1995;122:715–24.
2. Dalakas MC. Inflammatory muscle diseases. N Engl J Med 2015;372:1734–47.
3. Rider LG, Giannini EH, Brunner HI, Ruperto N, James-Newton L, Reed AM, et al. International consensus on preliminary definitions of improvement in adult and juvenile myositis. Arthritis Rheum 2004;50:2281–90.
4. Oddis CV, Rider LG, Reed AM, Ruperto N, Brunner HI, Koneru B, et al. International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies. Arthritis Rheum 2005;52:2607–15.
5. Medsger TA Jr, Dawson WN Jr, Masi AT. The epidemiology of polymyositis. Am J Med 1970;48:715–23.
6. DeVere R, Bradley WG. Polymyositis: its presentation, morbidity and mortality. Brain 1975;98:637–66.
7. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344–7.
8. Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975;292:403–7.
9. Griggs RC, Askanas V, DiMauro S, Engel A, Karpati G, Mendell JR, et al. Inclusion body myositis and myopathies. Ann Neurol 1995;38:705–13.
10. Tanimoto K, Nakano K, Kano S, Mori S, Ueki H, Nishitani H, et al. Classification criteria for polymyositis and dermatomyositis. J Rheumatol 1995;22:668–74.
11. Targoff IN, Miller FW, Medsger TA Jr, Oddis CV. Classification criteria for the idiopathic inflammatory myopathies. Curr Opin Rheumatol 1997;9:527–35.
12. Mastaglia FL, Phillips BA. Idiopathic inflammatory myopathies: epidemiology, classification, and diagnostic criteria. Rheum Dis Clin North Am 2002;28:723–41.
13. Van der Meulen MF, Bronner IM, Hoogendijk JE, Burger H, van Venrooij WJ, Voskuyl AE, et al. Polymyositis: an overdiagnosed entity. Neurology 2003;61:316–21.
14. Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet 2003;362:971–82.
15. Hoogendijk JE, Amato AA, Lecky BR, Choy EH, Lundberg IE, Rose MR, et al. 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, The Netherlands. Neuromuscul Disord 2004;14:337–45.
16. Troyanov Y, Targoff IN, Tremblay JL, Goulet JR, Raymond Y, Senécal JL. Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients. Medicine (Baltimore) 2005;84:231–49.
17. Miller FW, Rider LG, Plotz PH, Rutkove SB, Pestronk A, Wortmann RL, et al. Polymyositis: an overdiagnosed entity [letter]. Neurology 2004;63:402.
18. Bradley WG. Polymyositis: an overdiagnosed entity [letter]. Neurology 2004;63:402.
19. Hengstman GJ, van Engelen BG. Polymyositis: an overdiagnosed entity [letter]. Neurology 2004;63:402–3.
20. Engel AG, Arahata K. Mononuclear cells in myopathies: quantitation of functionally distinct subsets, recognition of antigen-specific cell-mediated cytotoxicity in some diseases, and implications for the pathogenesis of the different inflammatory myopathies. Hum Pathol 1986;17:704–21.
21. Betteridge Z, McHugh N. Myositis-specific autoantibodies: an important tool to support diagnosis of myositis. J Intern Med 2016;280:8–23.
22. Rider LG, Nistala K. The juvenile idiopathic inflammatory myopathies: pathogenesis, clinical and autoantibody phenotypes, and outcomes. J Intern Med 2016;280:24–38.
23. Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas M, Plotz PH, et al. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 1991;70:360–74.
24. Classification and Response Criteria Subcommittee of the American College of Rheumatology Committee on Quality Measures. Development of classification and response criteria for rheumatic diseases [editorial]. Arthritis Rheum 2006;55:348–52.
25. Dougados M, Gossec L. Classification criteria for rheumatic diseases: why and how? Arthritis Rheum 2007;57:1112–5.
26. Van de AH, Delbecq AL. The effectiveness of nominal, delphi, and interacting group decision making processes. Acad Manage J 1974;17:605–21.
27. Fink A, Kosecoff J, Chassin M, Brook RH. Consensus methods: characteristics and guidelines for use. Am J Public Health 1984;74:979–83.
28. Ruperto N, Meiorin S, Iusan SM, Ravelli A, Pistorio A, Martini A. Consensus procedures and their role in pediatric rheumatology. Curr Rheumatol Rep 2008;10:142–6.
29. Totikidis V. Applying the Nominal Group Technique (NGT) in community based action research for health promotion and disease prevention. Aust Community Psychol 2010;22:18–29.
30. ARA Glossary Committee. Dictionary of the rheumatic diseases. Vol. I. Signs and symptoms. New York: Contact Associates International; 1982.
31. ARA Glossary Committee. Dictionary of the rheumatic diseases. Vol. II. Diagnostic testing. New York: Contact Associates International; 1985.
32. Efron B, Tibshirani R. Improvements on cross-validation: the 632+ bootstrap method. J Am Stat Assoc 1997;92:548–60.
33. Hsiung SH, Chan EF, Elenitsas R, Kolasinski SL, Schumacher HR, Werth VP. Multicentric reticulohistiocytosis presenting with clinical features of dermatomyositis. J Am Acad Dermatol 2003;48 Suppl 2:S11–4.
34. Fett N, Liu RH. Multicentric reticulohistiocytosis with dermatomyositis-like features: a more common disease presentation than previously thought. Dermatology 2011;222:102–8.
35. Aggarwal R, Ringold S, Khanna D, Neogi T, Johnson SR, Miller A, et al. Distinctions between diagnostic and classification criteria? Arthritis Care Res (Hoboken) 2015;67:891–7.
36. Casciola-Rosen L, Mammen AL. Myositis autoantibodies. Curr Opin Rheumatol 2012;24:602–8.
37. Lloyd TE, Mammen AL, Amato AA, Weiss MD, Needham M, Greenberg SA. Evaluation and construction of diagnostic criteria for inclusion body myositis. Neurology 2014;83:426–33.